반응식
[CH3:1][C:2]1[CH2:13][CH:6]2[C:7](=[O:12])[NH:8][S:9](=[O:11])(=[O:10])[CH:5]2[CH2:4][C:3]=1[CH3:14].[Cl:15][C:16]1[N:21]=[C:20]([N:22]2[CH2:27][CH2:26][NH:25][CH2:24][CH2:23]2)[CH:19]=[N:18][CH:17]=1.[C:28]1(N)[C:33](F)=C(F)C(F)=[C:30](N)[C:29]=1F.[ClH:40].Cl>>[ClH:15].[ClH:40].[Cl:15][C:16]1[N:21]=[C:20]([N:22]2[CH2:23][CH2:24][N:25]([CH2:33][CH2:28][CH2:29][CH2:30][N:8]3[C:7](=[O:12])[CH:6]4[CH2:13][C:2]([CH3:1])=[C:3]([CH3:14])[CH2:4][CH:5]4[S:9]3(=[O:11])=[O:10])[CH2:26][CH2:27]2)[CH:19]=[N:18][CH:17]=1참가 물질
4
반응물 3
생성물 1
실험 절차
The title compound is prepared using the procedure of Example 1 using 3a,4,7,7a-tetrahydro-5,6-dimethyl-1,2-benzisothiazol-3-(2H)-one 1,1-dioxide instead of 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one 1,1-dioxide and 1-(6-chloro-2-pyrazinyl)piperazine instead of 4-(2-pyrimidinyl)piperazine. The final product is converted to its dihydrochloride salt, mp 158°-160° C.
후처리
- customThe title compound is prepared
출처 및 근거
- ORD 기록
- ord-4931d279d7594679a4d32efc8e4fd4c1
- 출처 데이터셋
- uspto-grants-1988_03
- 특허 번호
- US04732984
연결된 노트
불러오는 중…